Balchem’s (BCPC) Buy Rating Reiterated at HC Wainwright

HC Wainwright restated their buy rating on shares of Balchem (NASDAQ:BCPC) in a research report report published on Monday morning,Benzinga reports. HC Wainwright currently has a $190.00 target price on the basic materials company’s stock. HC Wainwright also issued estimates for Balchem’s Q1 2025 earnings at $0.99 EPS, Q2 2025 earnings at $1.03 EPS, Q3 2025 earnings at $1.08 EPS, Q4 2025 earnings at $1.12 EPS, FY2025 earnings at $4.22 EPS, Q1 2026 earnings at $1.13 EPS, Q2 2026 earnings at $1.17 EPS, Q3 2026 earnings at $1.20 EPS, Q4 2026 earnings at $1.22 EPS and FY2026 earnings at $4.71 EPS.

Separately, StockNews.com upgraded Balchem from a “hold” rating to a “buy” rating in a research report on Monday, October 28th.

Balchem Trading Down 0.5 %

Shares of BCPC opened at $172.69 on Monday. The company has a quick ratio of 1.16, a current ratio of 1.99 and a debt-to-equity ratio of 0.19. The stock has a market capitalization of $5.61 billion, a P/E ratio of 43.94, a PEG ratio of 4.41 and a beta of 0.69. Balchem has a twelve month low of $137.69 and a twelve month high of $186.03. The firm has a fifty day simple moving average of $162.13 and a two-hundred day simple moving average of $169.46.

Balchem (NASDAQ:BCPC) last posted its earnings results on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing the consensus estimate of $1.11 by ($0.08). The company had revenue of $240.00 million during the quarter, compared to analysts’ expectations of $239.96 million. Balchem had a return on equity of 11.37% and a net margin of 13.47%. On average, research analysts anticipate that Balchem will post 4.64 EPS for the current year.

Balchem Increases Dividend

The firm also recently announced an annual dividend, which was paid on Friday, January 17th. Stockholders of record on Thursday, December 26th were issued a dividend of $0.87 per share. This represents a dividend yield of 0.4%. This is a positive change from Balchem’s previous annual dividend of $0.79. The ex-dividend date was Thursday, December 26th. Balchem’s dividend payout ratio (DPR) is presently 22.14%.

Institutional Trading of Balchem

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Westside Investment Management Inc. purchased a new stake in shares of Balchem in the third quarter worth $27,000. Covestor Ltd grew its position in Balchem by 93.8% during the 4th quarter. Covestor Ltd now owns 157 shares of the basic materials company’s stock valued at $26,000 after purchasing an additional 76 shares during the last quarter. R Squared Ltd bought a new stake in Balchem during the 4th quarter valued at about $29,000. Wilmington Savings Fund Society FSB purchased a new position in Balchem in the third quarter worth about $35,000. Finally, Federated Hermes Inc. bought a new position in shares of Balchem in the fourth quarter worth approximately $33,000. Hedge funds and other institutional investors own 87.91% of the company’s stock.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.